PRO for Fighting FT in Ovarian Cancer
Condition:   Ovarian Cancer Intervention:   Other: Questionnaires Sponsor:   National Cancer Institute, Naples Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
Condition:   Ovarian Carcinoma Intervention:   Drug: Sacituzumab govitecan Sponsors:   Alessandro Santin;   Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials